CEL-SCI Corporation news

   Watch this stock
Showing stories 21 - 30 of about 87   

Articles published

CVM 1.87 +0.07 (3.89%)
price chart
CEL-SCI Corp (CVM) Prices $4.25M Common Stock, Warrants Offering
CEL-SCI Corporation (NYSE: CVM) announced that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 shares of common stock and warrants to purchase common stock at a price of $0.125.
CEL-SCI Announces Pricing of $4.25 Million Public Offering of Common Stock ...  Business Wire (press release)
FDA places CEL-SCI's late-stage Multikine study in head and neck cancer on ...
The FDA has notified CEL-SCI (NYSEMKT:CVM) that its Phase 3 clinical trial assessing Multikine (Leukocyte Interleukin, Injection) for the treatment of head and neck cancer is on full clinical hold, meaning that all dosing must cease immediately.
CEL-SCI Corporation (CVM) Stock: Takes A Dive On FDA Clinical Hold  CNA Finance (press release)
Lookout for Price Target? GTx, Inc. (GTXI), CEL-SCI Corporation (CVM)
CEL-SCI Corporation (NYSE:CVM), at its latest closing price of $0.08, it has a price-to-book ratio of 0.00, compared to an industry average at 18.73.
Blackrock Inc. is the third biggest owner of CEL-SCI Corporation (CVM)
CEL-SCI Corporation (NYSE:CVM) enjoyed a 18.49% run-up in share price since hitting record low of $1.46. The stock managed 4.85% rise and now stands at $1.73 as of September 22, 2017.
Negative Ichimoku Levels For Cel-Sci Corp (CVM) Indicate Bearish Momentum
Shares of Cel-Sci Corp (CVM) opened the last session at 1.80, touching a high of 1.92 and a low of 1.79 , yielding a change of 0.06.
Is CEL-SCI Corporation (NYSEMKT:CVM) in Danger of Delisting?
CEL-SCI Corporation (NYSEMKT:CVM) shares dipped 1.17% on Friday to $0.119 and flat in after-hours trading. The company has a market cap of $22.30 million at 190.22 million shares outstanding.
Will CEL-SCI Corporation(NYSEMKT:CVM) Be Delisted Soon?  ForexMinute.com
Analysts Layout Best- And Worst-Case Scenarios: Aduro BioTech, Inc. (ADRO ...
Aduro BioTech, Inc. (NASDAQ:ADRO) recent decline occurred on low volume with 0.37 million contracts changing hands on 13-Oct-17. That's down from its daily average of 0.4 million contracts.
CEL-SCI Working with FDA to Lift Hold on Phase 3 Trial of Multikine for Head ...
CEL-SCI Corp. has received the official minutes from its Type A (face-to-face) meeting with the U.S. Food and Drug Administration (FDA) concerning the partial clinical hold placed on a Phase 3 trial assessing Multikine (leukocyte interleukin, injection ...
Trading Tracker: Monitoring Shares of Cel-Sci Corp (CVM)
Monitoring the numbers for Cel-Sci Corp (CVM), we are noting that the KAMA is trending up over the last five days. Tracking this reading, traders might be on the lookout for positive near-term momentum.
Analyst Research and Recommendations: WABCO Holdings Inc. (WBC), CEL-SCI ...
WABCO Holdings Inc. (WBC) tinted loss of -1.13% (-1.69 points) to US$148.04. The volume of 0.32 Million shares climbed down over an trading activity of 377.3 Million shares.
Dawson James Reaffirms “Neutral” Rating for CEL-SCI Co. (CVM)  The Ledger Gazette
Target Price for Organovo Holdings, Inc. (ONVO) now above 50 DMA also CEL ...  NY Stock News